Д.К. Махкамова

6 works

Tashkent Institute of Postgraduate Medical Education, 51 Parkent St., Tashkent, Uzbekistan, 100009

1. Etiopathogenesis of ocular ischemic syndrome

   Д.К. Махкамова

   Review articleCerebrovascular and Carotid Artery DiseasesRussian Annals of Ophthalmology20171 citations

   ABIABI:AkademIndex/openalex/2017.review-article.000009

2. LEVEL OF MARKERS OF NEURODEGENERATION IN PATIENTS WITH OCULAR ISCHEMIC SYNDROME

   H. M. Kamilov, Munirahon Kasimova, Д.К. Махкамова

   ArticleNeurological Disorders and TreatmentsEuropean Medical Health and Pharmaceutical Journal20140 citations

   ABIABI:AkademIndex/openalex/2014.article.000504

3. EVALUATING THE EFFECTIVENESS OF FRUCTOSE-1,6-DIPHOSPHATE IN TREATING OF OCULAR ISCHEMIC SYNDROME

   Д.К. Махкамова

   ArticleCerebrovascular and Carotid Artery DiseasesEuropean Medical Health and Pharmaceutical Journal20150 citations

   ABIABI:AkademIndex/openalex/2015.article.000647

4. Analysis of choline alfoscerate effectiveness in chronic ocular ischemic syndrome

   Х. М. Камилов, М.С. Касимова, Д.К. Махкамова

   ArticleNeurological Disorders and TreatmentsRussian Annals of Ophthalmology20160 citations

   ABIABI:AkademIndex/openalex/2016.article.000349

5. Рenetrating operations of the eyeball as triggering factor of ocular ischemic syndrome

   Д.К. Махкамова

   ArticleCerebrovascular and Carotid Artery DiseasesOphthalmology in Russia20160 citations

   ABIABI:AkademIndex/openalex/2016.article.000543

6. Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration

   A.F. Yusupov, М.Х. Каримова, Sh.A. Djamalova +5

   ArticleRetinal Diseases and TreatmentsOftalmologicheskii Zhurnal20240 citations

   ABIABI:AkademIndex/openalex/2024.article.007191